Literature DB >> 18383529

Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon.

David Goldenberg1, Shahnaz Begum, William H Westra, Zubair Khan, James Sciubba, Sara I Pai, Joseph A Califano, Ralph P Tufano, Wayne M Koch.   

Abstract

BACKGROUND: : Cystic lymph node metastases have been associated with tonsil cancer. A subset of oropharyngeal cancers contain human papillomavirus (HPV) DNA. The clinical and virologic associations of cystic nodal metastasis in head and neck cancer (HNSCC) were investigated.
METHODS: : A retrospective review of patients undergoing neck dissection between 2002 and 2004 identified patients with cystic lymph node metastases. Clinical and pathologic information was recorded. The presence of HPV DNA was analyzed using in situ hybridization in a subset of patients.
RESULTS: : One hundred neck dissections were reviewed and 20 had cystic nodes. Seventeen of these patients had primary tumors arising in the palatine or lingual tonsil. Three were "unknown primary." HPV DNA was present in 11 of 13 patients with cystic metastases with tissue available for analysis (87%). No HPV DNA was identified in tumor from 21 patients with solid nodal metastasis (p <.0001).
CONCLUSION: : Cystic cervical lymph node metastasis is strongly associated with HPV-related tonsillar HNSCC: (c) 2008 Wiley Periodicals, Inc. Head Neck 2008.

Entities:  

Mesh:

Year:  2008        PMID: 18383529     DOI: 10.1002/hed.20796

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  95 in total

Review 1.  HPV-associated head and neck cancer: a virus-related cancer epidemic.

Authors:  Shanthi Marur; Gypsyamber D'Souza; William H Westra; Arlene A Forastiere
Journal:  Lancet Oncol       Date:  2010-05-05       Impact factor: 41.316

2.  Up-front neck dissection followed by concurrent chemoradiation in patients with regionally advanced head and neck cancer.

Authors:  Peter A Paximadis; Michael E Christensen; Greg Dyson; Dev P Kamdar; Ammar Sukari; Ho-Sheng Lin; George H Yoo; Harold E Kim
Journal:  Head Neck       Date:  2012-02-06       Impact factor: 3.147

Review 3.  Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.

Authors:  Kazuhiro Kitajima; Yuko Suenaga; Kazuro Sugimura
Journal:  Jpn J Radiol       Date:  2015-10-27       Impact factor: 2.374

4.  Adoption of transoral robotic surgery compared with other surgical modalities for treatment of oropharyngeal squamous cell carcinoma.

Authors:  Jennifer R Cracchiolo; Benjamin R Roman; David I Kutler; William I Kuhel; Marc A Cohen
Journal:  J Surg Oncol       Date:  2016-07-08       Impact factor: 3.454

5.  Human papillomavirus status of head and neck cancer as determined in cytologic specimens using the hybrid-capture 2 assay.

Authors:  David F Smith; Zahra Maleki; Diarmuid Coughlan; Zhen Gooi; Belinda Akpeng; Takenori Ogawa; Justin A Bishop; Kevin D Frick; Nishant Agrawal; Christine G Gourin; Patrick K Ha; Wayne M Koch; Jeremy D Richmon; William H Westra; Sara I Pai
Journal:  Oral Oncol       Date:  2014-03-12       Impact factor: 5.337

6.  Occult Primary Head and Neck Squamous Cell Carcinoma: Utility of Discovering Primary Lesions.

Authors:  Kara S Davis; J Kenneth Byrd; Vikas Mehta; Simon I Chiosea; Seungwon Kim; Robert L Ferris; Jonas T Johnson; Umamaheswar Duvvuri
Journal:  Otolaryngol Head Neck Surg       Date:  2014-05-08       Impact factor: 3.497

7.  Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas.

Authors:  William H Westra
Journal:  Oral Oncol       Date:  2014-06-02       Impact factor: 5.337

8.  Quantitative and qualitative analysis of [(18)F]FDG and [(18)F]FAZA positron emission tomography of head and neck cancers and associations with HPV status and treatment outcome.

Authors:  Edward E Graves; Rodney J Hicks; David Binns; Mathias Bressel; Quynh-Thu Le; Lester Peters; Richard J Young; Danny Rischin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-18       Impact factor: 9.236

9.  Recent advances in managing human papillomavirus-positive oropharyngeal tumors.

Authors:  Giulio Cantu; Stefano Riccio; Sarah Colombo; Madia Pompilio; Paolo Formillo
Journal:  F1000 Med Rep       Date:  2010-03-15

10.  Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base.

Authors:  Jennifer R Cracchiolo; Shrujal S Baxi; Luc G Morris; Ian Ganly; Snehal G Patel; Marc A Cohen; Benjamin R Roman
Journal:  Cancer       Date:  2016-03-11       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.